DrugsControl Media Services

News Detail

FDA approves a new weight loss drug, Eli Lilly's Zepbound (09-11-2023)

Indianapolis, 8 Nov 2023: In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly.


Wednesday, the Indianapolis-based company View Details

Source : Fierce Pharma
Eli Lilly weight loss Obesity GLP-1 tirzepatide FDA approval Fierce Pharma Homepage Pharma

Related News